Latest News

Should FAPI PET/CT be the New Standard of Care for Detecting Lymph Node Metastases in Patients with Lung Cancer?
Should FAPI PET/CT be the New Standard of Care for Detecting Lymph Node Metastases in Patients with Lung Cancer?

October 17th 2024

Examining six comparative studies within a new meta-analysis, researchers found that FAPI PET/CT offered 11 percent higher pooled sensitivity and 28 percent higher pooled specificity than FDG PET/CT for diagnosing lymph node metastases in patients with lung cancer.

Emerging AI Platform Shows Promise for Prostate Cancer Detection on mpMRI
Emerging AI Platform Shows Promise for Prostate Cancer Detection on mpMRI

October 17th 2024

Current Concepts in Active Surveillance for Prostate Cancer
Current Concepts in Active Surveillance for Prostate Cancer

October 17th 2024

FDA Clears Emerging AI-Powered Software for Brain MRI
FDA Clears Emerging AI-Powered Software for Brain MRI

October 16th 2024

FDA Grants Breakthrough Device Designation for Emerging High-Intensity Focused Ultrasound Treatment of Pancreatic Cancer
FDA Grants Breakthrough Device Designation for Emerging High-Intensity Focused Ultrasound Treatment of Pancreatic Cancer

October 16th 2024

Video Interviews

Latest Conference Coverage

View All
Advances in AI — June 2024
Advances in AI — June 2024

June 26th 2024

Study Examines Prognostic Value of 68Ga-PSMA-11 PET/CT for Patients at High Risk of PCa
Study Examines Prognostic Value of 68Ga-PSMA-11 PET/CT for Patients at High Risk of PCa

June 21st 2024

Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Emerging Research at SNMMI Examines 18F-Flotufolastat in Managing Primary and Recurrent Prostate Cancer

June 13th 2024

SNMMI: New Study Suggests Merits of FAPI PET/CT for Breast Cancer Staging
SNMMI: New Study Suggests Merits of FAPI PET/CT for Breast Cancer Staging

June 11th 2024

All News

© 2024 MJH Life Sciences

All rights reserved.